Literature DB >> 22770582

Hepatic steatosis assessment with 1H-spectroscopy and chemical shift imaging at 3.0 T before hepatic surgery: reliable enough for making clinical decisions?

Claus Koelblinger1, Martin Krššák, Judith Maresch, Fritz Wrba, Klaus Kaczirek, Thomas Gruenberger, Dietmar Tamandl, Ahmed Ba-Ssalamah, Vanessa Berger-Kulemann, Michael Weber, Wolfgang Schima.   

Abstract

PURPOSE: To compare the accuracy of liver fat quantification using chemical shift imaging (CSI) and H1 MR-spectroscopy (MRS) at 3.0 T in patients undergoing liver resection.
METHODS: Totally 35 patients were included in this prospective IRB approved study. The histopathologically assessed liver fat was compared to the hepatic fat fractions calculated with CSI (with and without spleen correction) and MRS. Spearman's rank correlation and Fisher z-test were used for correlation analysis. Sensitivity and specificity regarding the detection of marked steatosis were calculated for the different modalities and compared using the McNemar test.
RESULTS: MRS (r=.85) and CSI with spleen correction (r=.85) showed a significantly better correlation (p=.03) with histology compared to CSI without spleen correction (r=.67). Sensitivity and specificity for the detection of marked steatosis was 100% (12/12) and 87% (20/23) for MRS and 92% (11/12) and 83% (19/23) for CSI with spleen correction (p>.12).
CONCLUSION: For the assessment of hepatic steatosis both CSI with spleen correction and MRS at 3.0 T, show a good correlation with histology. CSI without spleen correction should not be used. Sensitivity and specificity for the detection of marked steatosis are high with both modalities. However, results that are scattered around the cut-off values are not reliable enough for clinical decisions.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22770582     DOI: 10.1016/j.ejrad.2012.01.025

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  9 in total

1.  Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis.

Authors:  Guido M Kukuk; Kanishka Hittatiya; Alois M Sprinkart; Holger Eggers; Jürgen Gieseke; Wolfgang Block; Philipp Moeller; Winfried A Willinek; Ulrich Spengler; Jonel Trebicka; Hans-Peter Fischer; Hans H Schild; Frank Träber
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

2.  Diffusion analysis with triexponential function in hepatic steatosis.

Authors:  Tatsuya Hayashi; Tosiaki Miyati; Junji Takahashi; Yoshinori Tsuji; Hidesato Suzuki; Naomi Tagaya; Mariko Hiramoto; Kei Fukuzawa; Masakatsu Tano; Satoshi Saitoh
Journal:  Radiol Phys Technol       Date:  2013-10-04

Review 3.  [Functional MR imaging of the liver].

Authors:  A Wibmer; R Nolz; M Trauner; A Ba-Ssalamah
Journal:  Radiologe       Date:  2015-12       Impact factor: 0.635

4.  Evaluation of MRI fat fraction in the liver and spine pre and post SPIO infusion.

Authors:  Joy Liau; Masoud Shiehmorteza; Olivier M Girard; Claude B Sirlin; Mark Bydder
Journal:  Magn Reson Imaging       Date:  2013-04-18       Impact factor: 2.546

5.  Comparison of Multi-Echo Dixon Methods with Volume Interpolated Breath-Hold Gradient Echo Magnetic Resonance Imaging in Fat-Signal Fraction Quantification of Paravertebral Muscle.

Authors:  Yeon Hwa Yoo; Hak-Sun Kim; Young Han Lee; Choon-Sik Yoon; Mun Young Paek; Hanna Yoo; Stephan Kannengiesser; Tae-Sub Chung; Ho-Taek Song; Jin-Suck Suh; Sungjun Kim
Journal:  Korean J Radiol       Date:  2015-08-21       Impact factor: 3.500

6.  The Efficacy of MRI in the diagnostic workup of cystic fibrosis-associated liver disease: A clinical observational cohort study.

Authors:  Sarah Poetter-Lang; Katharina Staufer; Pascal Baltzer; Dietmar Tamandl; Dina Muin; Nina Bastati; Emina Halilbasic; Jacqueline C Hodge; Michael Trauner; Lili Kazemi-Shirazi; Ahmed Ba-Ssalamah
Journal:  Eur Radiol       Date:  2018-07-27       Impact factor: 5.315

7.  Cardio-psycho-metabolic outcomes of bariatric surgery: design and baseline of the WAS trial.

Authors:  Ann-Cathrin Koschker; Bodo Warrings; Caroline Morbach; Florian Seyfried; Nicole Rickert; Pius Jung; Andreas Geier; Ulrich Dischinger; Maike Krauthausen; Martin J Herrmann; Christine Stier; Stefan Frantz; Uwe Malzahn; Stefan Störk; Martin Fassnacht
Journal:  Endocr Connect       Date:  2022-02-09       Impact factor: 3.335

8.  How to select the quantitative magnetic resonance technique for subjects with fatty liver: A systematic review.

Authors:  You-Wei Li; Yang Jiao; Na Chen; Qiang Gao; Yu-Kun Chen; Yuan-Fang Zhang; Qi-Ping Wen; Zong-Ming Zhang
Journal:  World J Clin Cases       Date:  2022-09-06       Impact factor: 1.534

9.  Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease.

Authors:  Jeong Woo Kim; Young-Sun Lee; Yang Shin Park; Baek-Hui Kim; Soo Yeon Lee; Jong Eun Yeon; Chang Hee Lee
Journal:  Sci Rep       Date:  2020-02-14       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.